Talos Co., Ltd. (CEO Kim Taek-kyun) participated in the 3th International Medical Equipment & Hospital Equipment Exhibition ‘KIMES 23’ held at COEX, Seoul from March 26 (Thu) to 38 (Sun).
Talos is a company that has developed a medical artificial intelligence (AI) model that contributes to the improvement of public health by using big data such as health insurance corporation data and medical treatment data to prevent brain diseases. To this end, the department of neurosurgery with AI research and development capabilities is the leader, and the executives and employees are composed of career positions in the fields of marketing, development, and medical administration.
In addition, through joint research with the best hospitals, including Seoul National University Hospital and Seoul National University Bundang Hospital, and Chonnam National University Hospital, the largest special health examination institution in Korea, the company is advancing the examination culture in the era of the 4th Industrial Revolution to prevent brain diseases. side explanation.
At this exhibition, Talos introduced its AI-based cerebral aneurysm risk assessment service ‘ANRISK’. It was introduced as a solution that can evaluate and diagnose the risk of developing a cerebral aneurysm using only the results of a health checkup, and is characterized by the application of a self-developed algorithm that can prevent cerebral and cardiovascular diseases.
People who belong to a relatively high-risk group can prevent subarachnoid hemorrhage through brain imaging, and those who have been evaluated for a relatively low risk can check specific health checkup factors to lower their risk of developing a cerebral aneurysm.
An official from Talos said, “By disclosing ANRISK, which was developed through big data and artificial intelligence, to the public, we intend to present a new cerebral aneurysm screening strategy solution to major domestic examination institutions.” There have been cases of not getting proper tests on time due to the cost of brain imaging tests, etc., and ANRISK will be a reasonable alternative to solve these problems.”
“ANRISK plans to launch in the first half of next year and expand its scope, targeting major university hospitals and health examination institutions,” he said. , We have a firm will to advance into the global market in the future.”
On the other hand, KIMES is an exhibition specializing in medical devices and hospital facilities that has grown steadily with the development of the Korean medical industry since its first meeting in 1980. It has transformed into a technology-intensive high-tech industry such as rehabilitation medicine.
In KIMES 2023, new technologies and products suitable for the era of convergence, such as smart healthcare in the era of the 4th industrial revolution, robot medical care and eco-friendly medical waste facilities, advanced hospital facilities, medical information systems combined with IT technology, and the automobile industry for rapid patient transportation, will be presented. showed off In addition, various information was provided, including seminars on medical technology, new technologies, and overseas marketing, as well as domestic medical industry policy seminars to show the latest information and the direction of the medical industry.
→ Go to KIMES 2023 news special page
